Safety and efficacy of PD-1/PD-L1 inhibitors combined with albumin-bound paclitaxel and fluorouracil-based agents as second-line therapy in biliary tract cancers

Abstract Background Biliary tract cancers (BTCs) are a group of highly aggressive malignancies with limited therapeutic options. Gemcitabine plus cisplatin (GemCis) remains the standard first-line regimen; however, the efficacy of currently recommended second-line therapies remains unsatisfactory. I...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Xiao Wang, Ying Zha, Pengen Li, Shumin Fu, Lin Xu, Weimin Jiang, Jianbing Wu, Ye Mao
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	BMC 2026-05-01
Serie:	World Journal of Surgical Oncology
Ämnen:	Albumin-bound paclitaxel Biliary tract cancers Immunotherapy Second-line therapy
Länkar:	https://doi.org/10.1186/s12957-026-04393-5
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!